Sartorius Stedim Biotech S.A./€DIM
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Sartorius Stedim Biotech S.A.
Sartorius Stedim Biotech S.A. specializes in providing equipment and services for the biopharmaceutical industry, focusing on products such as cell lines, cell culture media, bioreactors, and systems for separation, purification, and storage of biological products. Founded in 1978 and headquartered in Aubagne, France, the company operates globally with manufacturing and R&D sites in Europe, North America, and Asia. A subsidiary of Sartorius AG, Sartorius Stedim Biotech has expanded its portfolio through acquisitions, including the 2023 purchase of Polyplus-transfection SA for $2.7 billion. In 2023, the company reported sales revenue of approximately €2.8 billion and employed over 10,600 individuals worldwide. (,)
Ticker
€DIM
Sector
Primary listing
PAR
Employees
10,030
Headquarters
Website
DIM Metrics
BasicAdvanced
€17B
75.32
€2.31
0.93
€0.69
0.40%
Price and volume
Market cap
€17B
Beta
0.93
52-week high
€238.89
52-week low
€148.75
Average daily volume
12K
Dividend rate
€0.69
Financial strength
Current ratio
1.91
Quick ratio
1.063
Long term debt to equity
70.216
Total debt to equity
73.508
Dividend payout ratio (TTM)
29.80%
Interest coverage (TTM)
3.18%
Profitability
EBITDA (TTM)
695.1
Gross margin (TTM)
44.63%
Net profit margin (TTM)
7.78%
Operating margin (TTM)
15.58%
Effective tax rate (TTM)
20.32%
Revenue per employee (TTM)
€290,000
Management effectiveness
Return on assets (TTM)
3.44%
Return on equity (TTM)
5.69%
Valuation
Price to earnings (TTM)
75.317
Price to revenue (TTM)
5.856
Price to book
4.34
Price to tangible book (TTM)
-38.27
Price to free cash flow (TTM)
34.162
Free cash flow yield (TTM)
2.93%
Free cash flow per share (TTM)
5.098
Dividend yield (TTM)
0.40%
Forward dividend yield
0.40%
Growth
Revenue change (TTM)
5.44%
Earnings per share change (TTM)
28.09%
3-year revenue growth (CAGR)
-3.86%
10-year revenue growth (CAGR)
14.00%
3-year earnings per share growth (CAGR)
-30.12%
10-year earnings per share growth (CAGR)
9.12%
3-year dividend per share growth (CAGR)
-18.19%
10-year dividend per share growth (CAGR)
12.28%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Sartorius Stedim Biotech S.A. stock?
Sartorius Stedim Biotech S.A. (DIM) has a market cap of €17B as of August 26, 2025.
What is the P/E ratio for Sartorius Stedim Biotech S.A. stock?
The price to earnings (P/E) ratio for Sartorius Stedim Biotech S.A. (DIM) stock is 75.32 as of August 26, 2025.
Does Sartorius Stedim Biotech S.A. stock pay dividends?
Yes, the Sartorius Stedim Biotech S.A. (DIM) stock pays dividends to shareholders. As of August 26, 2025, the dividend rate is €0.69 and the yield is 0.4%. Sartorius Stedim Biotech S.A. has a payout ratio of 29.8% on a trailing twelve-month basis.
When is the next Sartorius Stedim Biotech S.A. dividend payment date?
The next Sartorius Stedim Biotech S.A. (DIM) dividend payment date is unconfirmed.
What is the beta indicator for Sartorius Stedim Biotech S.A.?
Sartorius Stedim Biotech S.A. (DIM) has a beta rating of 0.93. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.